1-tert-Butyl 4-methyl 4-allylpiperidine-1,4-dicarboxylate, 95.0%, 500mg

6-Bromo-8-methoxyimidazo[1,2-a]pyrazine, 95.0%, 5g

N,N-dimetilacetamida, mínimo 99%, para síntesis, 10 l, envase de plástico.

4-Cyano-3-(trifluoromethyl)acetanilide, 98.0%, 1g

1-(3-Chloro-4-(trifluoromethoxy)phenyl)ethanone, 95.0%, 5g

2,3-Dihydrofuro[3,2-c]pyridin-4-amine, 98%, 1g

(3-Methyloxetan-3-yl)methyl 4-methylbenzenesulfonate, 95.0%, 25g

2-(5-amino-3-methyl-1H-pyrazol-1-yl)-5,6-dimethylpyrimidin-4(3H)-one, 95.0%, 250mg

1-Pentylpiperazine dihydrochloride, 97%, 250mg

tert-butyl N-[(2-methylpropan-2-yl)oxycarbonyl]-N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]carbamate, 95%, 10g

5-Fluorocytosine>98.0%(HPLC)(T)5g

ethyl 3-[(2-methylpropyl)amino]propanoate, 95.0%, 10g

3-Chloro-5-hydroxy-2-methoxypyridine, 95%, 500mg